Clinical Trials in the EU / 2026-527632-13-00
Authorised, not yet recruiting
Phase I
Pharmacokinetics, safety and tolerability of tramadol after multiple-dose
2026-527632-13-00 · tracked via the Priya Life Science EU tracker
Condition studied
healthy participants
Eligibility
Official registry record
This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View 2026-527632-13-00 on CTIS ↗ ← All trials in the EU